191 related articles for article (PubMed ID: 19676100)
1. Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5(+/-);p53(+/-) mice.
DelBove J; Kuwahara Y; Mora-Blanco EL; Godfrey V; Funkhouser WK; Fletcher CD; Van Dyke T; Roberts CW; Weissman BE
Mol Carcinog; 2009 Dec; 48(12):1139-48. PubMed ID: 19676100
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.
Isakoff MS; Sansam CG; Tamayo P; Subramanian A; Evans JA; Fillmore CM; Wang X; Biegel JA; Pomeroy SL; Mesirov JP; Roberts CW
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17745-50. PubMed ID: 16301525
[TBL] [Abstract][Full Text] [Related]
3. Generation of a mouse model of atypical teratoid/rhabdoid tumor of the central nervous system through combined deletion of Snf5 and p53.
Ng JM; Martinez D; Marsh ED; Zhang Z; Rappaport E; Santi M; Curran T
Cancer Res; 2015 Nov; 75(21):4629-39. PubMed ID: 26363008
[TBL] [Abstract][Full Text] [Related]
4. SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development.
Wei D; Goldfarb D; Song S; Cannon C; Yan F; Sakellariou-Thompson D; Emanuele M; Major MB; Weissman BE; Kuwahara Y
Mol Cancer Res; 2014 Nov; 12(11):1574-85. PubMed ID: 25009291
[TBL] [Abstract][Full Text] [Related]
5. Tumor-specific cooperation of retinoblastoma protein family and Snf5 inactivation.
Chai J; Lu X; Godfrey V; Fletcher C; Roberts CW; Van Dyke T; Weissman BE
Cancer Res; 2007 Apr; 67(7):3002-9. PubMed ID: 17409406
[TBL] [Abstract][Full Text] [Related]
6. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
Caramel J; Medjkane S; Quignon F; Delattre O
Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
[TBL] [Abstract][Full Text] [Related]
7. Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF chromatin remodeling complex.
Klochendler-Yeivin A; Picarsky E; Yaniv M
Mol Cell Biol; 2006 Apr; 26(7):2661-74. PubMed ID: 16537910
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.
Kim KH; Roberts CW
Cancer Genet; 2014 Sep; 207(9):365-72. PubMed ID: 24853101
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors.
McKenna ES; Tamayo P; Cho YJ; Tillman EJ; Mora-Blanco EL; Sansam CG; Koellhoffer EC; Pomeroy SL; Roberts CW
Cell Cycle; 2012 May; 11(10):1956-65. PubMed ID: 22544318
[TBL] [Abstract][Full Text] [Related]
10. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5.
Roberts CW; Leroux MM; Fleming MD; Orkin SH
Cancer Cell; 2002 Nov; 2(5):415-25. PubMed ID: 12450796
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development.
Kuwahara Y; Mora-Blanco EL; Banine F; Rogers AB; Fletcher C; Sherman LS; Roberts CW; Weissman BE
Int J Cancer; 2013 Jun; 132(12):2767-77. PubMed ID: 23197309
[TBL] [Abstract][Full Text] [Related]
12. SNF5, a core component of the SWI/SNF complex, is necessary for p53 expression and cell survival, in part through eIF4E.
Xu Y; Yan W; Chen X
Oncogene; 2010 Jul; 29(28):4090-100. PubMed ID: 20473326
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumors.
Wöhrle S; Weiss A; Ito M; Kauffmann A; Murakami M; Jagani Z; Thuery A; Bauer-Probst B; Reimann F; Stamm C; Pornon A; Romanet V; Guagnano V; Brümmendorf T; Sellers WR; Hofmann F; Roberts CW; Graus Porta D
PLoS One; 2013; 8(10):e77652. PubMed ID: 24204904
[TBL] [Abstract][Full Text] [Related]
14. Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
Darr J; Klochendler A; Isaac S; Eden A
Oncogene; 2014 Jun; 33(23):3024-32. PubMed ID: 23851500
[TBL] [Abstract][Full Text] [Related]
15. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.
Wang X; Sansam CG; Thom CS; Metzger D; Evans JA; Nguyen PT; Roberts CW
Cancer Res; 2009 Oct; 69(20):8094-101. PubMed ID: 19789351
[TBL] [Abstract][Full Text] [Related]
16. Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability.
McKenna ES; Sansam CG; Cho YJ; Greulich H; Evans JA; Thom CS; Moreau LA; Biegel JA; Pomeroy SL; Roberts CW
Mol Cell Biol; 2008 Oct; 28(20):6223-33. PubMed ID: 18710953
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of MYC by the SMARCB1 tumor suppressor.
Weissmiller AM; Wang J; Lorey SL; Howard GC; Martinez E; Liu Q; Tansey WP
Nat Commun; 2019 May; 10(1):2014. PubMed ID: 31043611
[TBL] [Abstract][Full Text] [Related]
18. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice.
Roberts CW; Galusha SA; McMenamin ME; Fletcher CD; Orkin SH
Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13796-800. PubMed ID: 11095756
[TBL] [Abstract][Full Text] [Related]
19. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism.
Kuwahara Y; Charboneau A; Knudsen ES; Weissman BE
Cancer Res; 2010 Mar; 70(5):1854-65. PubMed ID: 20179200
[TBL] [Abstract][Full Text] [Related]
20. Snf5 tumor suppressor couples chromatin remodeling, checkpoint control, and chromosomal stability.
Imbalzano AN; Jones SN
Cancer Cell; 2005 Apr; 7(4):294-5. PubMed ID: 15837618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]